NOVACYT Aktie
| 0,42EUR | -0,02EUR | -5,27% | 
WKN DE: A12CFH / ISIN: FR0010397232
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 229 | 189 | 143 | 72 | 48 | 
| Summe Anlagevermögen | 33 | 30 | 15 | 83 | 38 | 
| Summe Aktiva | 262 | 219 | 159 | 154 | 85 | 
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 93 | 50 | 29 | 54 | 28 | 
| Summe Eigenkapital | 168 | 169 | 130 | 101 | 58 | 
| Summe Passiva | 262 | 219 | 159 | 154 | 85 | 
Adresse
| 131 Boulevard Carnot, 78110 Le Vésinet | |
| Telefon | +33 (1) 39-46-51-04 | 
| Fax | +33 (1) 30-70-05-32 | 
| Internet | http://www.novacyt.com | 
Management
| 
						Ian David Gilham
						 Non-Executive Director  | 
				
| 
						Jean-Pierre Crinelli
						 Independent Non-Executive Director  | 
				
| 
						Joanne Nicola Mason
						 Chief Scientific Officer & Executive Director  | 
				
| 
						John Robert Brown
						 Chairman  | 
				
| 
						Juliet Thompson
						 Independent Non-Executive Director  | 
				
| 
						Lyn Dafydd Rees
						 Chief Executive Officer & Executive Director  | 
				
| 
						Mandy Cowling
						 Manager-Corporate & Investor Relations  | 
				
| 
						Maria Watters
						 Chief Commercial Officer  | 
				
| 
						Steven Michael Gibson
						 Chief Financial Officer & Executive Director  |